Generics and Biosimilars Industry Supply Chain & Response to COVID-19 | Association for Accessible Medicines
New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework

Generics and Biosimilars Industry Supply Chain & Response to COVID-19

This presentation includes:

  • AAM Member Action: AAM members are working 24/7 to assure access and donating medicines and masks in response to the urgent needs created by the pandemic.
  • Supply Chain Visuals: How medicines actually get to patients is of increasing interest. These simplified schematics show the step-by-step journey of a generic or biosimilar drug from manufacturer to pharmacy and from manufacturer to hospital.
  • Supply Chain Overview: A more in-depth description of the links of the generic supply chain.

Download Presentation

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.